RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models
Ethnopharmacological relevance: Jian-yan-ling (JYL) is a drug used in traditional Chinese medicine (TCM) prescriptions for the treatment of tumors after radiotherapy and chemotherapy, to effectively alleviate leukocytopenia. However, the genetic mechanisms underlying the function of JYL remain uncle...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-05-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023033509 |
| _version_ | 1797815605399650304 |
|---|---|
| author | Xiaobo Zhang Yunliang Zhai Dandan Zhang Chang Che Yayun Zhang Quan Li Xue Zhang Lingrui Zhao |
| author_facet | Xiaobo Zhang Yunliang Zhai Dandan Zhang Chang Che Yayun Zhang Quan Li Xue Zhang Lingrui Zhao |
| author_sort | Xiaobo Zhang |
| collection | DOAJ |
| description | Ethnopharmacological relevance: Jian-yan-ling (JYL) is a drug used in traditional Chinese medicine (TCM) prescriptions for the treatment of tumors after radiotherapy and chemotherapy, to effectively alleviate leukocytopenia. However, the genetic mechanisms underlying the function of JYL remain unclear. Aim of the study: This study aimed to explore the RNA changes and potential biological processes related to the anti-aging or life-extending effects of JYL treatments. Materials and methods: In vivo treatments were performed using Canton-S Drosophila corresponding to three groups: control, low-concentration (low-conc.), and high-concentration (high-conc.) groups. The low-conc. And the high-conc. Groups were treated with 4 mg/mL JYL and 8 mg/mL JYL, respectively. Thirty Drosophila eggs were placed in each vial, and the third instar larvae and adults 7 and 21 days post-eclosion were collected for RNA sequencing, irrespective of the gender.In vitro treatments were conducted using humanized immune cell lines HL60 and Jurkat, which were divided into 3 groups: control (0 μg/mL JYL), low-concentration (40 μg/mL JYL), and high-concentration (80 μg/mL JYL). The cells were collected after 48 h of each JYL drug treatment. Both the Drosophila and cell samples were analyzed using RNA sequencing. Results: The in vivo experiments revealed 74 upregulated genes in the low-concentration group, and CG13078 was a commonly downregulated differential gene, which is involved in ascorbate iron reductase activity. Further analysis of the co-expression map identified the key genes: regulatory particle non-ATPase (RPN), regulatory particle triple-A ATPase (RPT), and tripeptidyl-peptidase II (TPP II). For the in vitro experiments, 19 co-differential genes were compared between different concentrations of the HL 60 cell line, of which three genes were upregulated: LOC107987457 (phostensin-like gene), HSPA1A (heat shock protein family A member 1 A), and H2AC19 (H2A clustered histone 19). In the HL 60 cell line, JYL activated proteasome-related functions. In the Jurkat cell line, there were no common differential genes despite the presence of a dosage-dependent trend. Conclusions: The RNA-seq results showed that the traditional Chinese medicine JYL has longevity and anti-aging effects, indicating that further investigation is required. |
| first_indexed | 2024-03-13T08:25:19Z |
| format | Article |
| id | doaj.art-e8018a11e5e4454b9611805ce2f82dff |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-13T08:25:19Z |
| publishDate | 2023-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-e8018a11e5e4454b9611805ce2f82dff2023-05-31T04:46:45ZengElsevierHeliyon2405-84402023-05-0195e16143RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro modelsXiaobo Zhang0Yunliang Zhai1Dandan Zhang2Chang Che3Yayun Zhang4Quan Li5Xue Zhang6Lingrui Zhao7School of Life Sciences, Fudan University, Shanghai, 200438, ChinaLei Yun Shang Pharmaceutical Group Co.,Ltd., Suzhou, 215009, ChinaLei Yun Shang Pharmaceutical Group Co.,Ltd., Suzhou, 215009, ChinaKey Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, 310024, ChinaLei Yun Shang Pharmaceutical Group Co.,Ltd., Suzhou, 215009, ChinaLei Yun Shang Pharmaceutical Group Co.,Ltd., Suzhou, 215009, ChinaLei Yun Shang Pharmaceutical Group Co.,Ltd., Suzhou, 215009, ChinaKey Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, 310024, China; Corresponding author.Ethnopharmacological relevance: Jian-yan-ling (JYL) is a drug used in traditional Chinese medicine (TCM) prescriptions for the treatment of tumors after radiotherapy and chemotherapy, to effectively alleviate leukocytopenia. However, the genetic mechanisms underlying the function of JYL remain unclear. Aim of the study: This study aimed to explore the RNA changes and potential biological processes related to the anti-aging or life-extending effects of JYL treatments. Materials and methods: In vivo treatments were performed using Canton-S Drosophila corresponding to three groups: control, low-concentration (low-conc.), and high-concentration (high-conc.) groups. The low-conc. And the high-conc. Groups were treated with 4 mg/mL JYL and 8 mg/mL JYL, respectively. Thirty Drosophila eggs were placed in each vial, and the third instar larvae and adults 7 and 21 days post-eclosion were collected for RNA sequencing, irrespective of the gender.In vitro treatments were conducted using humanized immune cell lines HL60 and Jurkat, which were divided into 3 groups: control (0 μg/mL JYL), low-concentration (40 μg/mL JYL), and high-concentration (80 μg/mL JYL). The cells were collected after 48 h of each JYL drug treatment. Both the Drosophila and cell samples were analyzed using RNA sequencing. Results: The in vivo experiments revealed 74 upregulated genes in the low-concentration group, and CG13078 was a commonly downregulated differential gene, which is involved in ascorbate iron reductase activity. Further analysis of the co-expression map identified the key genes: regulatory particle non-ATPase (RPN), regulatory particle triple-A ATPase (RPT), and tripeptidyl-peptidase II (TPP II). For the in vitro experiments, 19 co-differential genes were compared between different concentrations of the HL 60 cell line, of which three genes were upregulated: LOC107987457 (phostensin-like gene), HSPA1A (heat shock protein family A member 1 A), and H2AC19 (H2A clustered histone 19). In the HL 60 cell line, JYL activated proteasome-related functions. In the Jurkat cell line, there were no common differential genes despite the presence of a dosage-dependent trend. Conclusions: The RNA-seq results showed that the traditional Chinese medicine JYL has longevity and anti-aging effects, indicating that further investigation is required.http://www.sciencedirect.com/science/article/pii/S2405844023033509Jian-yan-ling (JYL) drugRNA sequencingDrosophila melanogasterHL60 cell lineProtein ubiquitination decompositionanti-aging |
| spellingShingle | Xiaobo Zhang Yunliang Zhai Dandan Zhang Chang Che Yayun Zhang Quan Li Xue Zhang Lingrui Zhao RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models Heliyon Jian-yan-ling (JYL) drug RNA sequencing Drosophila melanogaster HL60 cell line Protein ubiquitination decomposition anti-aging |
| title | RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models |
| title_full | RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models |
| title_fullStr | RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models |
| title_full_unstemmed | RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models |
| title_short | RNAseq analysis of the drug jian-yan-ling (JYL) using both in vivo and in vitro models |
| title_sort | rnaseq analysis of the drug jian yan ling jyl using both in vivo and in vitro models |
| topic | Jian-yan-ling (JYL) drug RNA sequencing Drosophila melanogaster HL60 cell line Protein ubiquitination decomposition anti-aging |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023033509 |
| work_keys_str_mv | AT xiaobozhang rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT yunliangzhai rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT dandanzhang rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT changche rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT yayunzhang rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT quanli rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT xuezhang rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels AT lingruizhao rnaseqanalysisofthedrugjianyanlingjylusingbothinvivoandinvitromodels |